List of SBIR/STTR awards granted to Cytonus Therapeutics
Cytonus TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Cytonus Therapeutics in June, 2020 for $386,586.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA250887-01 | Phase I | 386,586 | June 15, 2020 | |||||||
A STTR Phase I contract was awarded to Cytonus Therapeutics in September, 2020 for $399,346.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA257020-01 | Phase I | 399,346 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Cytonus Therapeutics in July, 2021 for $454,975.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL158351-01 | Phase I | 454,975 | July 16, 2021 | |||||||
A SBIR Phase I contract was awarded to Cytonus Therapeutics in September, 2021 for $297,553.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL156665-01 | Phase I | 297,553 | September 20, 2021 | |||||||
A STTR Phase I contract was awarded to Cytonus Therapeutics in August, 2021 for $324,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41TR003960-01A1 | Phase I | 324,986 | August 20, 2021 | |||||||
A SBIR Phase II contract was awarded to Cytonus Therapeutics in September, 2023 for $1,148,542.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA250887-02A1 | Phase II | 1,148,542 | September 1, 2023 |
